Back to Search
PAUL REISS, MD
MD
Family Medicine Physician
NPI: 1275628158IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
0420007213(VT)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
OTHER
Class of 1983
Research & Publications (20)
On distance-based permutation tests for between-group comparisons.
PMID 19673867·Biometrics·2010
8-other
Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).
PMID 19188509·Circulation·2009
8-other
Nevirapine increases high-density lipoprotein cholesterol concentration by stimulation of apolipoprotein A-I production.
PMID 19667106·Arterioscler Thromb Vasc Biol·2009
3-trial
Effect of poly(ethylene glycol) length on the in vivo behavior of coated quantum dots.
PMID 19437711·Langmuir·2009
7-preclinical
Increase in carotid artery intima-media thickness and arterial stiffness but improvement in several markers of endothelial function after initiation of antiretroviral therapy.
PMID 19275490·J Infect Dis·2009
4-observational
Zidovudine/lamivudine for HIV-1 infection contributes to limb fat loss.
PMID 19479079·PLoS One·2009
2-rct
First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir.
PMID 19424051·AIDS·2009
4-observational
L-dopa modulates functional connectivity in striatal cognitive and motor networks: a double-blind placebo-controlled study.
PMID 19494158·J Neurosci·2009
2-rct
Expanding the scope of protein trans-splicing to fragment ligation of an integral membrane protein: towards modulation of porin-based ion channels by chemical modification.
PMID 19322843·Chembiochem·2009
8-other
Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy.
PMID 19487907·AIDS·2009
4-observational
Hepatitis C virus coinfection does not influence the CD4 cell recovery in HIV-1-infected patients with maximum virologic suppression.
PMID 19360931·J Acquir Immune Defic Syndr·2009
4-observational
On the function and structure of synthetically modified porins.
PMID 19322865·Angew Chem Int Ed Engl·2009
8-other
Continuous antiretroviral therapy decreases bone mineral density.
PMID 19531929·AIDS·2009
4-observational
Absence of a relation between efavirenz plasma concentrations and toxicity-driven efavirenz discontinuations in the EuroSIDA study.
PMID 19320239·Antivir Ther·2009
8-other
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.
PMID 19275498·Clin Infect Dis·2009
8-other
Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression.
PMID 19668084·J Acquir Immune Defic Syndr·2009
8-other
Carotid intima-media thickness and arterial stiffness in HIV-infected patients: the role of HIV, antiretroviral therapy, and lipodystrophy.
PMID 19131894·J Acquir Immune Defic Syndr·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 28 PARK AVE
WILLISTON, VT 05495 - Phone
- (802) 878-1008
Quick Facts
- NPI
- 1275628158
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile